Jefferson Reporter

U.S. Senator Katie Britt has acknowledged October as National Breast Cancer Awareness Month, urging women to consult with healthcare providers and undergo screenings. This month serves as a reminder for women to learn about the benefits of regular screening and potential risk factors associated with breast cancer.

Earlier this year, the U.S. Preventative Services Task Force (USPSTF) revised its guidelines, recommending that women begin biennial breast cancer screenings at age 40 instead of 50 due to an increase in invasive breast cancer cases among younger women. The Breast Cancer Research Foundation of Alabama reports that one in eight women will face an invasive breast cancer diagnosis during their lifetime, with around 4,000 cases expected in Alabama this year.

The American Cancer Society projects approximately 310,720 new invasive breast cancer cases nationwide in 2024, with 16% affecting women under 50. Rising rates among younger women often lead to delayed diagnoses and more challenging late-stage tumors.

Senator Britt emphasized the importance of early detection: “This Breast Cancer Awareness month, I am encouraging every woman across Alabama and America to put their health first and talk to their doctor this month to discuss the best individual screening plan for them. As rates in breast cancer continue to rise in younger women, the importance of regular screening cannot be understated. Early detection saves lives.”

Britt also called on Congress to support the Access to Breast Cancer Diagnosis (ABCD) Act, co-sponsored by Senator Jeanne Shaheen. The act aims to make diagnostic testing more affordable by eliminating copays and other out-of-pocket expenses for such tests.

As a member of the Senate Committee on Appropriations Subcommittee on Labor, Health and Human Services, Education, and Related Agencies, Britt is focused on improving access to diagnostic testing for women across America. A study published by Radiology highlighted that 40.6% of women might skip additional imaging if deductibles are required.

Current insurance policies mandate no-copay coverage for initial screenings but not for subsequent diagnostic tests necessary after a positive screening result or for those predisposed genetically or with previous diagnoses.

The ABCD Act has garnered strong support from organizations like the American Society of Breast Surgeons and the Susan G. Komen foundation.